1. A new protocol for exercise testing in COPD; improved prediction algorithm for and validation of the endurance test in a placebo-controlled double bronchodilator study
- Author
-
Ellen Tufvesson, Finn Radner, Anton Simonsen, Georgia Papapostolou, Linnea Jarenbäck, Saga Jönsson, Ulf Nihlen, Alf Tunsäter, Jaro Ankerst, Stefan Peterson, Leif Bjermer, and Göran Eriksson
- Subjects
Diseases of the respiratory system ,RC705-779 - Abstract
Background: Two new protocols have been developed for bicycle exercise testing in chronic obstructive pulmonary disease (COPD) with an individualized cardiopulmonary exercise test (ICPET) and subsequent customized endurance test (CET), which generate less interindividual spread in endurance time compared with the standard endurance test. Main objectives of this study were to improve the prediction algorithm for W MAX for the ICPET and validate the CET by examining treatment effects on exercise performance of indacaterol/glycopyrronium (IND/GLY) compared with placebo. Methods: COPD patients, with forced expiratory volume in 1 s ( FEV 1 ) 40–80% predicted, were recruited. Pooled baseline data from two previous studies ( n = 38) were used for the development of an improved W MAX prediction algorithm. Additional COPD patients ( n = 14) were recruited and performed the ICPET, using the new prediction formula at visit 1. Prior to the CET at visits 2 and 3, they were randomized to a single dose of IND/GLY (110/50 µg) or placebo. Results: The improved multiple regression algorithm for W MAX includes diffusing capacity for carbon monoxide ( DLCO ), FEV 1 , sex , age and height and correlated to measured W MAX ( R 2 = 0.89 and slope = 0.89). Treatment with IND/GLY showed improvement in endurance time versus placebo, mean 113 s [95% confidence interval (CI): 6–220], p = 0.037, with more prominent effect in patients with FEV 1
- Published
- 2021
- Full Text
- View/download PDF